Preoperative BRAF(V600E) mutation screening is unlikely to alter initial surgical treatment of patients with indeterminate thyroid nodules: A prospective case series of 960 patients Academic Article uri icon

Overview

MeSH Major

  • Proto-Oncogene Proteins B-raf
  • Thyroid Nodule

abstract

  • Preoperative mutation screening for BRAF(V600E) does not meaningfully improve risk stratification and is unlikely to alter the initial management of patients with indeterminate nodules.

publication date

  • April 15, 2013

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1002/cncr.27888

PubMed ID

  • 23280049

Additional Document Info

start page

  • 1495

end page

  • 502

volume

  • 119

number

  • 8